• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer.全面的生物信息学分析确定同源盒B9为胃癌潜在的预后生物标志物和治疗靶点。
J Gastrointest Oncol. 2021 Oct;12(5):2132-2149. doi: 10.21037/jgo-21-598.
2
Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.基于综合生物信息学分析鉴定 HOXB9 预测头颈部鳞状细胞癌的预后。
Medicine (Baltimore). 2023 Sep 1;102(35):e35035. doi: 10.1097/MD.0000000000035035.
3
High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma.HOXB3 高表达预示肺腺癌不良预后且与肿瘤免疫相关。
Mol Biol Rep. 2022 Apr;49(4):2607-2618. doi: 10.1007/s11033-021-07064-8. Epub 2022 Jan 14.
4
Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.膜联蛋白 A8 可作为卵巢癌潜在的预后生物标志物和治疗靶点:基于膜联蛋白的综合分析。
J Transl Med. 2019 Sep 2;17(1):275. doi: 10.1186/s12967-019-2023-z.
5
Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.评估 MT 家族同工型作为预测胃癌进展和预后的潜在生物标志物。
Biomed Res Int. 2019 Jul 17;2019:2957821. doi: 10.1155/2019/2957821. eCollection 2019.
6
Experimental and clinicopathological analysis of HOXB9 in gastric cancer.胃癌中HOXB9的实验与临床病理分析
Oncol Lett. 2019 Mar;17(3):3097-3102. doi: 10.3892/ol.2019.10008. Epub 2019 Feb 4.
7
The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer.E2F1-HOXB9/PBX2-CDK6 轴驱动胃肿瘤发生,是胃癌的治疗靶点。
J Pathol. 2023 Aug;260(4):402-416. doi: 10.1002/path.6091. Epub 2023 Jun 5.
8
Vestigial like family member 3 is a novel prognostic biomarker for gastric cancer.类残迹家族成员3是一种新型的胃癌预后生物标志物。
World J Clin Cases. 2019 Aug 6;7(15):1954-1963. doi: 10.12998/wjcc.v7.i15.1954.
9
MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.基于生物信息学分析和实验,MTFR2作为一种潜在的预后和免疫浸润生物标志物,促进胃癌进展
J Cancer. 2021 Apr 26;12(12):3611-3625. doi: 10.7150/jca.58158. eCollection 2021.
10
Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer.HOXB9 的过表达促进结肠癌转移并预示不良预后。
Chin J Cancer Res. 2014 Feb;26(1):72-80. doi: 10.3978/j.issn.1000-9604.2014.01.11.

引用本文的文献

1
DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression.DNMT1阻断SOX21抑制的CKS2转录以促进胃癌进展。
BMC Cancer. 2025 Jul 17;25(1):1182. doi: 10.1186/s12885-025-14577-z.
2
A pan-cancer analysis of homeobox family: expression characteristics and latent significance in prognosis and immune microenvironment.同源框家族的泛癌分析:表达特征及其在预后和免疫微环境中的潜在意义
Front Oncol. 2025 Feb 6;15:1521652. doi: 10.3389/fonc.2025.1521652. eCollection 2025.
3
GGT5 as a promising prognostic biomarker and its effects on tumor cell progression in gastric cancer.γ-谷氨酰转移酶5作为一种有前景的预后生物标志物及其对胃癌肿瘤细胞进展的影响。
Transl Cancer Res. 2024 Aug 31;13(8):4459-4473. doi: 10.21037/tcr-23-2222. Epub 2024 Aug 23.

本文引用的文献

1
HOX genes promote cell proliferation and are potential therapeutic targets in adrenocortical tumours.HOX 基因促进细胞增殖,是肾上腺皮质肿瘤的潜在治疗靶点。
Br J Cancer. 2021 Feb;124(4):805-816. doi: 10.1038/s41416-020-01166-z. Epub 2020 Nov 20.
2
Methylation in Clusters and Its Applications in Cancer Therapy.簇状甲基化及其在癌症治疗中的应用。
Cells. 2020 Jul 3;9(7):1613. doi: 10.3390/cells9071613.
3
The MicroRNA hsa-let-7g Promotes Proliferation and Inhibits Apoptosis in Lung Cancer by Targeting HOXB1.miRNA hsa-let-7g 通过靶向 HOXB1 促进肺癌增殖并抑制细胞凋亡。
Yonsei Med J. 2020 Mar;61(3):210-217. doi: 10.3349/ymj.2020.61.3.210.
4
Silencing of HOXB9 suppresses cellular proliferation, angiogenesis, migration and invasion of prostate cancer cells.HOXB9 的沉默抑制了前列腺癌细胞的增殖、血管生成、迁移和侵袭。
J Biosci. 2020;45.
5
miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2.miR-4324通过靶向HOXB2在结直肠癌中发挥肿瘤抑制作用。
J Int Med Res. 2020 Mar;48(3):300060519883731. doi: 10.1177/0300060519883731. Epub 2019 Dec 18.
6
LINC01006 promotes cell proliferation and metastasis in pancreatic cancer via miR-2682-5p/HOXB8 axis.LINC01006通过miR-2682-5p/HOXB8轴促进胰腺癌的细胞增殖和转移。
Cancer Cell Int. 2019 Dec 2;19:320. doi: 10.1186/s12935-019-1036-2. eCollection 2019.
7
MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia.MiR-340是急性髓系白血病中用于选择化疗和异基因移植治疗的生物标志物。
Front Oncol. 2019 Oct 11;9:1058. doi: 10.3389/fonc.2019.01058. eCollection 2019.
8
HOXA10 deteriorates gastric cancer through activating JAK1/STAT3 signaling pathway.HOXA10通过激活JAK1/STAT3信号通路使胃癌恶化。
Cancer Manag Res. 2019 Jul 15;11:6625-6635. doi: 10.2147/CMAR.S201342. eCollection 2019.
9
Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.胃肝样腺癌:具有独特临床病理和分子特征的独特亚群。
Gastric Cancer. 2019 Nov;22(6):1183-1192. doi: 10.1007/s10120-019-00965-5. Epub 2019 Apr 15.
10
Experimental and clinicopathological analysis of HOXB9 in gastric cancer.胃癌中HOXB9的实验与临床病理分析
Oncol Lett. 2019 Mar;17(3):3097-3102. doi: 10.3892/ol.2019.10008. Epub 2019 Feb 4.

全面的生物信息学分析确定同源盒B9为胃癌潜在的预后生物标志物和治疗靶点。

Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer.

作者信息

Li Xiaofei, Chen Shujia, Zhu Yinghui, Fei Jiayue, Song Liaoyuan, Sun Guoyan, Niu Wei, Guo Lianyi, Wang Jiwei

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

Department of Gastrointestinal Surgery, Xuzhou Central Hospital, Xuzhou, China.

出版信息

J Gastrointest Oncol. 2021 Oct;12(5):2132-2149. doi: 10.21037/jgo-21-598.

DOI:10.21037/jgo-21-598
PMID:34790380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8576221/
Abstract

BACKGROUND

The Homeobox B () family promotes tumor progression, but the mechanism of its action in gastric cancer (GC) is unclear. We sought to identify the family members that are critical to the prognosis of GC patients.

METHODS

The Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA), cBioPortal, UALCAN, Kaplan-Meier plotter, and the GeneMANIA databases were used to analyze the messenger RNA (mRNA) expression levels, prognostic value, and gene-gene interaction network of the family members in GC. The expression of in GC and its relationship with various clinicopathological parameters and the prognosis of patients were verified by immunohistochemistry.

RESULTS

The expression of , , and mRNA was significantly upregulated in GC. There was a significant correlation between the upregulation of , and mRNA and a low overall survival (OS) rate. The high expression of , , and mRNA was closely correlated to tumor grade and stage. was the family member most closely related to the occurrence and development of GC. A further analysis showed that might be involved in deoxyribonucleic acid repair and division regulation. A validation study showed that the advanced cancer group had a higher level of expression than the early cancer group. The high expression of in gastric tissue plays an important role in the survival and prognosis of GC patients.

CONCLUSIONS

HOXB family members have different degrees of abnormal expression in GC. High expression in GC tissues was significantly correlated with a worse prognosis. Thus, is a potential novel biomarker and therapeutic target for GC.

摘要

背景

同源盒B(HOXB)家族促进肿瘤进展,但其在胃癌(GC)中的作用机制尚不清楚。我们试图确定对GC患者预后至关重要的HOXB家族成员。

方法

使用Oncomine、基因表达谱交互分析(GEPIA)、cBioPortal、UALCAN、Kaplan-Meier绘图仪和GeneMANIA数据库分析HOXB家族成员在GC中的信使核糖核酸(mRNA)表达水平、预后价值和基因-基因相互作用网络。通过免疫组织化学验证HOXB在GC中的表达及其与各种临床病理参数和患者预后的关系。

结果

HOXB5、HOXB7和HOXB9的mRNA在GC中表达显著上调。HOXB5、HOXB7和HOXB9的mRNA上调与低总生存率(OS)之间存在显著相关性。HOXB5、HOXB7和HOXB9的mRNA高表达与肿瘤分级和分期密切相关。HOXB9是与GC发生发展最密切相关的HOXB家族成员。进一步分析表明,HOXB9可能参与脱氧核糖核酸修复和分裂调控。一项验证研究表明,晚期癌症组的HOXB9表达水平高于早期癌症组。胃组织中HOXB9的高表达在GC患者的生存和预后中起重要作用。

结论

HOXB家族成员在GC中存在不同程度的异常表达。GC组织中HOXB9的高表达与较差的预后显著相关。因此,HOXB9是GC潜在的新型生物标志物和治疗靶点。